Background and Purpose-Patients with symptomatic intracranial atherosclerot
ic stenosis have a high rate of recurrence. We conducted a prospective stud
y to determine which factors are associated with the progression of symptom
atic middle cerebral artery (MCA) stenosis and to evaluate the relationship
between progression and clinical recurrence.
Methods-Between January 1996 and February 2000, of a total of 2564 consecut
ive first-ever transient ischemic attack (TIA) or stroke patients admitted
to Our cerebrovascular unit, 145 showed an MCA stenosis signal on transcran
ial Doppler (TCD) on admission, and 40 fulfilled all criteria to enter this
study, including angiographic confirmation. Patients were prescribed antip
latelet or anticoagulant agents following the criteria of the neurologist i
n charge. TCD recordings and clinical interviews were performed regularly d
uring follow-up. Progression of MCA stenosis was defined as an increase > 3
0 cm/s in TCD-recorded maximum mean flow velocity. Logistic regression anal
yses were used to identify predictors of progression and clinical recurrenc
e.
Results-With a median follow-up of 26.55 months, 13 (32.5%) MCA stenoses pr
ogressed. 3 (7.5%) regressed, and 24 (60%) remained stable. Absence of sign
ificant extracranial internal carotid artery (ICA) stenosis (P=0.049) and t
he use of oral anticoagulants (P=0.045) were significantly associated with
a lower progression rate in univariate analysis, and anticoagulation remain
ed an independent predictor when a logistic regression model was applied (O
R 7.25, CI 1.1 to 48.1. P=0.019). A new ischemic event during follow-up in
the territory Supplied by the stenosed MCA occurred in 8 cases (20%). and 1
3 patients had a major vascular event. Progression of the MCA stenosis dete
cted by TCD was independently associated with a new ipsilateral ischemic ev
ent (OR 2.89, CI 1.09 to 7.71, P=0.031) and with the occurrence of any majo
r vascular event (OR 7.03, CI 1.6 to 30.9, P=0.0071).
Conclusions-Progression of symptomatic MCA stenosis detected by means of TC
D predicts clinical recurrence. Anticoagulation is independently associated
with a lower progression rate of symptomatic MCA stenosis.